PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient. This company was founded by Aditya Khosla and Andrew Beck in 2016 and is headquartered in Greater Boston Area, NE. PathAI services solve challenging pathology problems faced by the research and pharmaceutical industry.

Register for Details

For more details on financing and valuation for PathAI, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is PathAI's ticker symbol?

PathAI does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is PathAI's stock price?

The stock price for PathAI will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are PathAI's major investors?

Tiger Global Management
Polaris Partners
D1 Capital Partners
Kaiser Permanente
General Catalyst

PathAI Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/19/2021 Series C $1.11B $XXX.XX $XXX.XX
11/4/2019 Series B $410.6MM $XXX.XX $XXX.XX
11/3/2017 Series A, A1, A2, A3, and A4 $55.11MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about PathAI

Forge green plus iconForge green minus icon

What is PathAI funding to date?

PathAI has raised $255.49MM with the following series:
$55.11MM for Series A, A1, A2, A3, and A4, $410.6MM for Series B, $1.11B for Series C, $55.11MM for Series A, A1, A2, A3, and A4, $410.6MM for Series B, $1.11B for Series C.
Forge green plus iconForge green minus icon

When was PathAI founded?

PathAI was founded in 2016.
Forge green plus iconForge green minus icon

Can you invest in PathAI?

PathAI is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell PathAI share pre-IPO?

If you own PathAI pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is PathAI a publicly traded company?

PathAI is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like PathAI in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector